Puberty blockers, blocked
Should some children be given drugs to stop them going through puberty?
That’s the question the NHS, the government and an independent research and ethics committee have been trying to answer.
The “Pathways” trial, backed by the NHS and led by a team from King’s College London, aims to test the effectiveness and safety of puberty blockers for children experiencing gender dysphoria.
At the end of 2025, the trial was approved to go ahead. Health Secretary Wes Streeting reassured parliamentary colleagues it “could not have received more oversight and scrutiny”.
But now the agency in charge of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.